EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieÄquivalenzstudie

Endoscopic ultrasound-guided fine-needle biopsy with or without macroscopic on-site evaluation: a randomized controlled noninferiority trial

Benedetto Mangiavillano iD, Stefano Francesco Crinò, Antonio Facciorusso iD, Francesco Di Matteo, Carmelo Barbera, Alberto Larghi, Gianenrico Rizzatti, Silvia Carrara, Marco Spadaccini, Francesco Auriemma, Carlo Fabbri, Cecilia Binda iD und 16 weitere

Endoscopy · 2023-02 · 55 (02) · 129-137

DOI: 10.1055/a-1915-5263 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Endoscopy, online erschienen am 31.08.2022. Verfasst von Benedetto Mangiavillano und 27 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Endoscopy Unit, Humanitas Mater Domini - Castellanza, Varese, Italy. Hauptthemen laut MEDLINE: Pancreatic Neoplasms. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The advantage of using the macroscopic on-site evaluation (MOSE) technique during endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) performed with 22G Franseen needles has not been investigated. We aimed to compare EUS-FNB with MOSE vs. EUS-FNB performed with three needle passes.

Methods

This randomized trial involved 10 Italian referral centers. Consecutive patients referred for EUS-FNB of pancreatic or nonpancreatic solid lesions were included in the study and randomized to the two groups. MOSE was performed by gross visualization of the collected material by the endoscopists and considered adequate when a white/yellowish aggregate core longer than 10 mm was retrieved. The primary outcome was diagnostic accuracy. Secondary outcomes were specimen adequacy, number of needle passes, and safety.

Results

370 patients with 234 pancreatic lesions (63.2 %) and 136 nonpancreatic lesions (36.8 %) were randomized (190 EUS-FNB with MOSE and 180 with standard EUS-FNB). No statistically significant differences were found between EUS-FNB with MOSE and conventional EUS-FNB in terms of diagnostic accuracy (90.0 % [95 %CI 84.8 %–93.9 %] vs. 87.8 % [95 %CI 82.1 %–92.2 %]; P = 0.49), sample adequacy (93.1 % [95 %CI 88.6 %–96.3 %] vs. 95.5 % [95 %CI 91.4 %–98 %]; P = 0.31), and rate of adverse events (2.6 % vs. 1.1 %; P = 0.28). The median number of passes was significantly lower in the EUS-FNB with MOSE group (1 vs. 3; P < 0.001).

Conclusions

The accuracy of EUS-FNB with MOSE is noninferior to that of EUS-FNB with three needle passes. MOSE reliably assesses sample adequacy and reduces the number of needle passes required to obtain the diagnosis with a 22G Franseen needle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsHumansEndoscopic Ultrasound-Guided Fine Needle AspirationImage-Guided BiopsyPancreasMorpholinesOrganoselenium Compounds

Substanzen

di-beta-(morpholinoethyl)selenideMorpholinesOrganoselenium Compounds

Autor:innen und Institutionen

  • Gastrointestinal Endoscopy Unit, Humanitas Mater Domini - Castellanza, Varese, Italy.
  • Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy.
  • Gastroenterology and Digestive Endoscopy Unit, The Pancreas Institute, G.B. Rossi University Hospital, Verona, Italy.
  • Gastroenterology Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
  • Digestive Endoscopy, Università Campus Bio Medico, Rome, Italy.
  • Digestive Endoscopy, Hospital of Teramo, Teramo, Italy.

ORCID-Profile: Benedetto Mangiavillano, Antonio Facciorusso, Cecilia Binda, Gianmarco Marocchi, Germana De Nucci, Gianpiero Manes, Laura Lamonaca, Danilo Paduano

Zitieren

APA

Mangiavillano, B., Crinò, S. F., Facciorusso, A., Di Matteo, F., Barbera, C., Larghi, A., Rizzatti, G., Carrara, S., Spadaccini, M., Auriemma, F., Fabbri, C., Binda, C., Coluccio, C., Marocchi, G., Staiano, T., Conti Bellocchi, M. C., Bernardoni, L., Eusebi, L. H., Cirota, G. G., …, & Repici, A. (2023). Endoscopic ultrasound-guided fine-needle biopsy with or without macroscopic on-site evaluation: a randomized controlled noninferiority trial. Endoscopy, 55(02), 129-137. https://doi.org/10.1055/a-1915-5263

Vancouver

Mangiavillano B, Crinò SF, Facciorusso A, Di Matteo F, Barbera C, Larghi A, et al. Endoscopic ultrasound-guided fine-needle biopsy with or without macroscopic on-site evaluation: a randomized controlled noninferiority trial. Endoscopy. 2023;55(02):129-137. doi:10.1055/a-1915-5263

BibTeX
@article{Mangiavillano2023,
  author = {Mangiavillano, Benedetto and Crinò, Stefano Francesco and Facciorusso, Antonio and Di Matteo, Francesco and Barbera, Carmelo and Larghi, Alberto and Rizzatti, Gianenrico and Carrara, Silvia and Spadaccini, Marco and Auriemma, Francesco and Fabbri, Carlo and Binda, Cecilia and Coluccio, Chiara and Marocchi, Gianmarco and Staiano, Teresa and Conti Bellocchi, Maria Cristina and Bernardoni, Laura and Eusebi, Leonardo Henri and Cirota, Giovanna Grazia and De Nucci, Germana and Stigliano, Serena and Manes, Gianpiero and Bonanno, Giacomo and Ofosu, Andrew and Lamonaca, Laura and Paduano, Danilo and Spatola, Federica and Repici, Alessandro},
  title = {Endoscopic ultrasound-guided fine-needle biopsy with or without macroscopic on-site evaluation: a randomized controlled noninferiority trial},
  journal = {Endoscopy},
  year = {2023},
  volume = {55},
  number = {02},
  pages = {129--137},
  doi = {10.1055/a-1915-5263}
}
Kostenlos starten →